Akèy › Maladi Crohn › Minnesota
Etid klinik pou Maladi Crohn nan Minnesota
11 etid pou Maladi Crohn ap chèche patisipan nan sit nan Minnesota.
Vil nan Minnesota
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Mayo Clinic in Rochester, Minnesota ( Site 5024), Rochester
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Mayo Clinic-Rochester /ID# 265550, Rochester
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Mayo Clinic 1, Rochester
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196722A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- MNGI Digestive Health, P. A. /ID# 255366, Minneapolis
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 23, 2026 · NCT05995353Standardized Microbiota Transplant Therapy in Crohn's Disease
- University of Minnesota, Minneapolis
Ap rekriteFaz 2
Laj 18 a 89 · Tout sèks · Mizajou Sep 8, 2026 · NCT06631586Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- MNGI Digestive Health, P. A. /ID# 262204, Minneapolis
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Jun 24, 2026 · NCT06332534A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- MNGI Digestive Health, PA, Minneapolis
- Mayo Clinic - PIN, Rochester
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou May 5, 2026 · NCT0477932068Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
- Mayo Clinic, Rochester
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT07273188Treatment of Moderate to Severe Refractory Crohn's Disease
- Mayo Clinic Rochester, Rochester
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Dec 10, 2025 · NCT06721962Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
- Mayo Clinic- Rochester, Rochester
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT06670638Helmsley 3.0: Abbreviated MRE
- Mayo Clinic, Rochester
Ap rekriteEtid obsèvasyon
Laj 10 ak plis · Tout sèks · Mizajou Oct 27, 2025 · NCT06533228Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.